GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Female sex;
Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm);
Planned new line of systemic antineoplastic treatment;
Age of 18 years or older;
Pregnant or breastfeeding women;
Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve);
Diagnosis of symptomatic VTE at the time of screening for enrollment.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
Fondazione Umberto Veronesi
Collaborator